An overview of experience with ketoconazole shampoo.Br J Clin Pract. 1991 Winter; 45(4):279-84.BJ
Abstract
The spectrum of disease known as dandruff/seborrhoeic dermatitis has been shown to be due to infection of the skin by the Pityrosporon species of fungus. Ketoconazole shampoo has been shown to suppress effectively both the organism's growth and the symptoms and signs of the clinical disorder.
MeSH
Pub Type(s)
Journal Article
Review
Language
eng
PubMed ID
1839767
Citation
Ive, F A.. "An Overview of Experience With Ketoconazole Shampoo." The British Journal of Clinical Practice, vol. 45, no. 4, 1991, pp. 279-84.
Ive FA. An overview of experience with ketoconazole shampoo. Br J Clin Pract. 1991;45(4):279-84.
Ive, F. A. (1991). An overview of experience with ketoconazole shampoo. The British Journal of Clinical Practice, 45(4), 279-84.
Ive FA. An Overview of Experience With Ketoconazole Shampoo. Br J Clin Pract. 1991;45(4):279-84. PubMed PMID: 1839767.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - An overview of experience with ketoconazole shampoo.
A1 - Ive,F A,
PY - 1991/1/1/pubmed
PY - 1991/1/1/medline
PY - 1991/1/1/entrez
SP - 279
EP - 84
JF - The British journal of clinical practice
JO - Br J Clin Pract
VL - 45
IS - 4
N2 - The spectrum of disease known as dandruff/seborrhoeic dermatitis has been shown to be due to infection of the skin by the Pityrosporon species of fungus. Ketoconazole shampoo has been shown to suppress effectively both the organism's growth and the symptoms and signs of the clinical disorder.
SN - 0007-0947
UR - https://www.unboundmedicine.com/medline/citation/1839767/An_overview_of_experience_with_ketoconazole_shampoo_
DB - PRIME
DP - Unbound Medicine
ER -
Latest evidence on COVID-19 from PubMed, WHO, CDC.
Visit free Relief Central.
Visit free Relief Central.
Try the Free App:
